235 related articles for article (PubMed ID: 27022296)
1. Renal cell carcinoma: links and risks.
Kabaria R; Klaassen Z; Terris MK
Int J Nephrol Renovasc Dis; 2016; 9():45-52. PubMed ID: 27022296
[TBL] [Abstract][Full Text] [Related]
2. Review of renal cell carcinoma and its common subtypes in radiology.
Low G; Huang G; Fu W; Moloo Z; Girgis S
World J Radiol; 2016 May; 8(5):484-500. PubMed ID: 27247714
[TBL] [Abstract][Full Text] [Related]
3. Renal cell carcinoma.
Hsieh JJ; Purdue MP; Signoretti S; Swanton C; Albiges L; Schmidinger M; Heng DY; Larkin J; Ficarra V
Nat Rev Dis Primers; 2017 Mar; 3():17009. PubMed ID: 28276433
[TBL] [Abstract][Full Text] [Related]
4. Systemic therapy in metastatic renal cell carcinoma.
Bedke J; Gauler T; Grünwald V; Hegele A; Herrmann E; Hinz S; Janssen J; Schmitz S; Schostak M; Tesch H; Zastrow S; Miller K
World J Urol; 2017 Feb; 35(2):179-188. PubMed ID: 27277600
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of Renal Cell Carcinoma.
Capitanio U; Bensalah K; Bex A; Boorjian SA; Bray F; Coleman J; Gore JL; Sun M; Wood C; Russo P
Eur Urol; 2019 Jan; 75(1):74-84. PubMed ID: 30243799
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic neuroendocrine tumor with solitary splenic metastasis and synchronous renal cell carcinoma: A rare case report.
Abera MT; Seman YS; Mohammed HY; Abrar FN; Mikru AM; Mersha MK
Radiol Case Rep; 2024 Jul; 19(7):2760-2766. PubMed ID: 38680748
[TBL] [Abstract][Full Text] [Related]
7. Impact of the COVID-19 pandemic on diagnosis of renal cell carcinoma and disease stage at presentation.
Janes WCI; Fagan MG; Andrews JM; Harvey DR; Warden GM; Johnston PH; Organ MK
Can Urol Assoc J; 2024 Apr; 18(4):E113-E119. PubMed ID: 38381938
[TBL] [Abstract][Full Text] [Related]
8. Polygenic risk score model for renal cell carcinoma in the Korean population and relationship with lifestyle-associated factors.
Hong JY; Han JH; Jeong SH; Kwak C; Kim HH; Jeong CW
BMC Genomics; 2024 Jan; 25(1):46. PubMed ID: 38200428
[TBL] [Abstract][Full Text] [Related]
9. An Overview of Renal Cell Carcinoma Hallmarks, Drug Resistance, and Adjuvant Therapies.
DA Silva Prade J; DE Souza RS; DA Silva D'Αvila CM; DA Silva TC; Livinalli IC; Bertoncelli ACZ; Saccol FK; DE Oliveira Mendes T; Wenning LG; DA Rosa Salles T; Rhoden CRB; Cadona FC
Cancer Diagn Progn; 2023; 3(6):616-634. PubMed ID: 37927802
[TBL] [Abstract][Full Text] [Related]
10. KL is a favorable prognostic factor related immune for clear cell renal cell carcinoma.
Pan KH; Yao L; Chen Z; Sun J; Jia Z; Zhang J; Ling Z
Eur J Med Res; 2023 Sep; 28(1):356. PubMed ID: 37726833
[TBL] [Abstract][Full Text] [Related]
11. Expression Pattern of Sonic Hedgehog, Patched and Smoothened in Clear Cell Renal Carcinoma.
Dunatov Huljev A; Kelam N; Benzon B; Šoljić V; Filipović N; Pešutić Pisac V; Glavina Durdov M; Vukojević K
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240278
[TBL] [Abstract][Full Text] [Related]
12. Atypical Nelson Syndrome Following Right Partial and Left Total Nephrectomy With Incidental Bilateral Total Adrenalectomy of Renal Cell Carcinoma: A Chat Generative Pre-Trained Transformer (ChatGPT)-Assisted Case Report and Literature Review.
Schuppe K; Burke S; Cohoe B; Chang K; Lance RS; Mroch H
Cureus; 2023 Mar; 15(3):e36042. PubMed ID: 37056551
[TBL] [Abstract][Full Text] [Related]
13. Management of Metastatic Renal Cell Carcinoma in a Tertiary Care Hospital.
Kumar S; Singh V; Singh MK; Sankhwar SN
Cureus; 2023 Feb; 15(2):e35623. PubMed ID: 37007390
[TBL] [Abstract][Full Text] [Related]
14. Survival Improvement in Patients with Renal Cell Carcinoma and Disparities between Different Sexes, Races, and Socioeconomic Status: 1977-2016.
Ouyang D; Sun H; Chen N; Yan Y; Ma H; Xia J
J Oncol; 2022; 2022():1587365. PubMed ID: 35942409
[TBL] [Abstract][Full Text] [Related]
15. Comparative Analysis for the Distinction of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma in Computed Tomography Imaging Using Machine Learning Radiomics Analysis.
Alhussaini AJ; Steele JD; Nabi G
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892868
[No Abstract] [Full Text] [Related]
16. A Cluster of Metabolic-Related Genes Serve as Potential Prognostic Biomarkers for Renal Cell Carcinoma.
Huang S; Luo Q; Huang J; Wei J; Wang S; Hong C; Qiu P; Li C
Front Genet; 2022; 13():902064. PubMed ID: 35873461
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of Gut Microbiota in Patients With Clear Cell Renal Cell Carcinoma.
Chen Y; Ma J; Dong Y; Yang Z; Zhao N; Liu Q; Zhai W; Zheng J
Front Microbiol; 2022; 13():913718. PubMed ID: 35865926
[TBL] [Abstract][Full Text] [Related]
18. Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma.
Sharma R; Kannourakis G; Prithviraj P; Ahmed N
Front Med (Lausanne); 2022; 9():766869. PubMed ID: 35775004
[TBL] [Abstract][Full Text] [Related]
19. Potential Influence of Age and Diabetes Mellitus Type 1 on MSH2 (MutS homolog 2) Expression in a Rat Kidney Tissue.
Babić P; Filipović N; Hamzić LF; Puljak L; Vukojević K; Benzon B
Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741815
[TBL] [Abstract][Full Text] [Related]
20. Frequency of Acquired Renal Cystic Disease in Patients on Long-Term Hemodialysis and Associated Renal Cell Carcinoma.
Ali F; Aziz JB; Saleem S; Khan SI; Khan S; Khan SI
Cureus; 2022 Apr; 14(4):e24547. PubMed ID: 35651425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
